Tag: UNM Comprehensive Cancer Center

New Treatment May Help Those with Rare Immune Cancers

New Treatment May Help Those with Rare Immune Cancers

By Michele Sequeira | September 13, 2016
Mastocytosis is a rare, sometimes deadly, immune disorder that most people have never heard of. It is a shapeshifter. With the indolent form of the disease, some people have mild symptoms and lead normal lives, while others may develop flushing, diarrhea and life-threatening anaphylactic shock. In advanced mastocytosis, sufferers develop mast cell leukemia, and most die within six months.
UNM Cancer Center joins Biden's 'Cancer Moonshot'

UNM Cancer Center joins Biden's 'Cancer Moonshot'

By John Arnold | June 29, 2016
Dozens of cancer researchers, doctors, advocates and survivors gathered at the UNM Comprehensive Cancer Center Wednesday as part of Vice President Joe Biden's "Cancer Moonshot" – a new national initiative to speed up the battle against cancer.
UNM radiopharmacy program continues pioneering ways

UNM radiopharmacy program continues pioneering ways

March 15, 2016
In 1972, UNM’s on-campus nuclear pharmacy opened for business – the only licensed nuclear pharmacy in the world. Today, UNM is one of only a few pharmacy schools that offer radiopharmacy education and training, has an active research arm, and offers students practical experience in the on-campus pharmacy that once again fills orders and prepares doses for customers in Albuquerque.
New brain cancer therapy showing promise

New brain cancer therapy showing promise

By Michele Sequeira | February 03, 2016
Researchers at the University of New Mexico Comprehensive Cancer Center say a new two-drug combination is showing promising results in the battle against a deadly brain cancer, glioblastoma.
$453,000 grant to help UNM researchers study blood disorders

$453,000 grant to help UNM researchers study blood disorders

By Michele Sequeira | December 15, 2015
Researchers at the University of New Mexico Comprehensive Cancer Center will use a two-year $453,000 grant to develop new treatments for slowly-progressing but very serious blood cancers in which the bone marrow makes too many red blood cells, white blood cells or platelets.
New clinical trial targets pancreatic cancer

New clinical trial targets pancreatic cancer

By Michele Sequeira | November 03, 2015
The University of New Mexico Comprehensive Cancer Center is taking aim at one of the deadliest cancers in the world with a new clinical trial that could help more people undergo surgery to remove pancreatic tumors.